FDA’s Discussion of Disease Awareness and Prescription Drug Communications on Television: Evidence for Conflation and Misleading Product Impressions
The FDA’s Center for Drug Evaluation and Research conducted a study examining the relationship between disease communications and prescription drug advertising. The results are discussed